Patents Assigned to Montefiore Medical Center
  • Patent number: 5635204
    Abstract: The applicants have discovered that by simultaneously administering particular combinations of drugs at particular dosage levels by means of a transdermal delivery system, anesthesia may be induced in patients requiring such treatment. It has been found that profound sedation or an analgesic effect may be produced by means of a particular combination of pharmacologic agents which are administered simultaneously by transdermal administration. A patch system has been devised which is useful for reversing anesthesia.
    Type: Grant
    Filed: March 4, 1994
    Date of Patent: June 3, 1997
    Assignee: Montefiore Medical Center
    Inventors: Clifford Gevirtz, Hideo Nagashima, David P. Katz
  • Patent number: 5569584
    Abstract: The present application is directed to a method for distinguishing between normally differentiated and benign or malignantly transformed cells in human colonic tissue. It is also directed to a method for monitoring the state of premalignant or malignant human colonic tissue. In both methods, a 50F1 complementary DNA standard probe is utilized which hybridizes to the RNA in the test sample and to a second sample, which is a predetermined sample of colonic tissue, and the amount of hybridization of the 50F1 complementary DNA to the test sample is compared to the hybridization of the 50F1 complementary DNA with the second sample.
    Type: Grant
    Filed: March 14, 1994
    Date of Patent: October 29, 1996
    Assignee: Montefiore Medical Center
    Inventor: Leonard H. Augenlicht
  • Patent number: 5545629
    Abstract: A composition comprising 5-ethoxy-2'-deoxyuridine is disclosed which is useful as an antiviral agent.
    Type: Grant
    Filed: April 12, 1994
    Date of Patent: August 13, 1996
    Assignee: Montefiore Medical Center
    Inventors: Brian A. Otter, Edward L. Schwartz
  • Patent number: 5498708
    Abstract: A new process is disclosed for the preparation of esters of polyhydroxy compounds having three or more hydroxy compounds. The process is based on the reaction with an alkyl chloroformate to form a mixed anhydride which is contacted with a polyol.
    Type: Grant
    Filed: July 18, 1989
    Date of Patent: March 12, 1996
    Assignee: Montefiore Medical Center
    Inventor: Iraj Lalezari
  • Patent number: 5496810
    Abstract: The applicants have discovered a method of treating malignancies which comprises administering effective amounts of 5-fluorouracil, interferon-.alpha. and a compound formula (I): ##STR1## wherein R is selected is selected from the group consisting of alkyl of 1 to 5 carbon atoms, alkene of 2 to 5 carbon atoms and alkynyl of 2 to 5 carbon atoms; R.sub.1 is 2'-deoxyribofuranosyl.
    Type: Grant
    Filed: April 12, 1994
    Date of Patent: March 5, 1996
    Assignee: Montefiore Medical Center
    Inventor: Edward L. Schwartz
  • Patent number: 5472981
    Abstract: The present invention is concerned with a method for treating hemoglobin or blood in vivo or in vitro to modify the affinity of hemoglobin for oxygen, said method comprising causing an effective amount of a substituted arylureidophenoxymethyl propionic acid to come in contact with hemoglobin.
    Type: Grant
    Filed: November 29, 1993
    Date of Patent: December 5, 1995
    Assignee: Montefiore Medical Center
    Inventors: Iraj Lalezari, Parviz Lalezari
  • Patent number: 5444064
    Abstract: The present invention provides a method for the treatment of a malignancy sensitive to a treatment regimen which comprises administering by injection to a host afflicted with said malignancy 5-fluorouracil at a dose of 600-100 mg/m.sup.2 /day followed by the administration of from 2-40 million international units of alpha-2a-interferon.
    Type: Grant
    Filed: February 28, 1989
    Date of Patent: August 22, 1995
    Assignee: Montefiore Medical Center
    Inventor: Scott Wadler
  • Patent number: 5385731
    Abstract: A novel method for the treatment of hyperlipidemia/high serum cholesterol is disclosed which is based on the parenteral administration of granulocyte colony stimulating factor.
    Type: Grant
    Filed: November 14, 1991
    Date of Patent: January 31, 1995
    Assignee: Montefiore Medical Center
    Inventors: Parviz Lalezari, Manouchehr Khorshidi
  • Patent number: 5378601
    Abstract: The invention provides a method and composition for preserving platelets which is based on the use of a composition which includes apyrase and an antioxidant. Preferred compositions will also include a protease inhibitor and optionally a solvent.
    Type: Grant
    Filed: July 24, 1992
    Date of Patent: January 3, 1995
    Assignee: Montefiore Medical Center
    Inventor: Elena Gepner-Puszkin
  • Patent number: 5315512
    Abstract: The disclosure is directed to an apparatus and method for producing a three-dimensional image representation of a body. The body can be animate or inanimate; i.e. the invention can be used to obtain 3D image representations of for example, parts of the human body or any object that one wishes to view or measure. The 3D image representations can be used to produce 2D displays of sections, contours, etc., or displays having 3D perspective, such as wire-frame type illustrations. This facilitates automatic computation of areas or volumes. In a disclosed embodiment, an ultrasonic imaging subsystem is provided for producing signals representative of two-dimensional images of sections of the body, the subsystem including a scanning transducer that is moveable to determine the section of the body to be imaged. The image representative signals are stored as arrays of digital pixel values.
    Type: Grant
    Filed: September 1, 1989
    Date of Patent: May 24, 1994
    Assignee: Montefiore Medical Center
    Inventor: James A. Roth
  • Patent number: 5292935
    Abstract: The present invention is concerned with a process for the synthesis of substituted arylureidophenoxymethyl propionic acids and an analogous benzamides series of compounds which have activity in the dissociation of oxygen from hemoglobin. In addition the process may be utilized to prepare compounds which are known.
    Type: Grant
    Filed: January 15, 1992
    Date of Patent: March 8, 1994
    Assignee: Montefiore Medical Center
    Inventors: Iraj Lalezari, Parviz Lalezari
  • Patent number: 5268500
    Abstract: Novel compounds are disclosed which have the formula: ##STR1## wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4 may be the same or different and independently selected from the group consisting of hydrogen, halogen, straight and branched chain alkyl of from 1-6 carbon atoms, aryl, cycloalkyl of 4 to 7 carbon atoms; and alkoxy of 1 to 6 carbon atoms; R.sub.5 and R.sub.6 may be the same or different and are selected from the group consisting of hydrogen, halogen, straight and branched chain alkyl groups of from 1-6 carbon atoms, aralkyl groups wherein the alkyl portion has from 1-6 carbon atoms cycloalkyl of from 4-7 carbon atoms and aryl; R.sub.7 is hydrogen or a straight or branched chain alkyl group of 1-6 carbon atoms and the pharmaceutically acceptable salts thereof.These compounds are useful for the treatment of hyperlipidemia and for the in vivo and in vitro treatment of hemoglobin or blood to modify the affinity of hemoglobin for oxygen.
    Type: Grant
    Filed: October 18, 1991
    Date of Patent: December 7, 1993
    Assignees: Montefiore Medical Center, City of Hope
    Inventors: Iraj Lalezari, Samuel Rahbar, Parviz Lalezari
  • Patent number: 5093367
    Abstract: The present invention is concerned with a process for the synthesis of substituted arylureidophenexymethyl propionic acids and an analogous benzamides series of compounds which have activity in the dissociation of oxygen from hemoglobin. In addition the process may be utilized to prepare compounds which are known.
    Type: Grant
    Filed: February 7, 1990
    Date of Patent: March 3, 1992
    Assignee: Montefiore Medical Center
    Inventors: Iraj Lalezari, Parviz Lalezari
  • Patent number: 4981783
    Abstract: A method is disclosed for the analysis of gene expression in human biopsy that is useful in the diagnosis and prognosis of disease and evaluation of risk for disease. The method comprises the steps of compiling data regarding the level of expression of certain individual cloned gene sequences from patients having defined pathological conditions and from normal patients and thereafter identifying sequences that characterize the pathological condition.The data regarding the expression of the individual cloned genes are stored in a defined pattern or array. Replicas of this array are hybridized to radioactive probes made using the RNA isolated from biopsy tissue. The extent of hybridization of the probe to each of the cloned sequences is proportional to the level of expression of the cloned sequence in the tissue from which the probe was made. This may be done by exposing the hybridized clones to x-ray film and scanning the x-ray films to quantify the cloned sequences.
    Type: Grant
    Filed: April 16, 1986
    Date of Patent: January 1, 1991
    Assignee: Montefiore Medical Center
    Inventor: Leonard Augenlicht
  • Patent number: 4921997
    Abstract: The present invention is concerned with a process for the synthesis of substituted arylureidophenexymethyl propionic acids and an analogous benzamides series of compounds which have activity in the dissociation of oxygen from hemoglobin. In addition, the process may be utilized to prepare compounds which are known.
    Type: Grant
    Filed: June 15, 1988
    Date of Patent: May 1, 1990
    Assignee: Montefiore Medical Center
    Inventors: Iraj Lalezari, Parviz Lalezari
  • Patent number: 4780542
    Abstract: The invention relates to the preparation of an ester or an amide from an anhydride with an alcohol or an amine, wherein the anhydride is first prepared by reacting an acid and an alkyl chloroformate in a 100% aqueous medium, that is, 100% water.
    Type: Grant
    Filed: September 26, 1983
    Date of Patent: October 25, 1988
    Assignee: Montefiore Medical Center
    Inventor: Iraj Lalezari
  • Patent number: 4575484
    Abstract: A method for detecting the presence of Mycobacteria in a fluid or tissue which comprises mixing the fluid or tissue containing a secretory product of Mycobacteria with a complex of a tracer-containing molecule and a binding macromolecule having reversible binding affinity for the tracer-containing molecule detecting the tracer-containing molecule, wherein the tracer-containing molecule is a charcoal-adsorbable protein from Mycobacterium tuberculosis which has a molecular weight of 20,000-30,000 and which is immunochemically stable from 4.degree. C. to 250.degree. C. and has a pH range from 3.0 to 9.0. The method is particularly applicable to the detection of infectious tuberculosis in humans and determining the antibiotic sensitivity of infecting Mycobacteria.
    Type: Grant
    Filed: September 23, 1982
    Date of Patent: March 11, 1986
    Assignee: Montefiore Medical Center, Inc.
    Inventor: Eugene W. Straus
  • Patent number: 4418059
    Abstract: A composition comprising a nucleosidic anti-tumor agent esterified with a carboxylic acid-containing steroid is described. These steroid ester derivatives of, for example, a deoxyuridine compound provide enhanced anti-tumor effects in chemotherapy as compared to the corresponding nucleosides alone.
    Type: Grant
    Filed: July 20, 1981
    Date of Patent: November 29, 1983
    Assignees: Montefiore Medical Center, The Albert Einstein College of Medicine at Yeshiva University
    Inventor: Iraj Lalezari
  • Patent number: 4410660
    Abstract: A method for detecting the presence of Mycobacteria in a fluid or tissue which comprises mixing the fluid or tissue containing a secretory product of Mycobacteria with a complex of a tracer-containing molecule and a binding macromolecule having reversible binding affinity for the tracer-containing molecule and detecting the tracer-containing molecule, wherein the tracer-containing molecule is a charcoal-adsorbable protein from Mycobacterium tuberculosis which has a molecular weight of 20,000-30,000 and which is immunochemically stable from 4.degree.0 C. to 250.degree. C. and has a pH range from 3.0 to 9.0. The method is particularly applicable to the detection of infectious tuberculosis in humans and determining the antibiotic sensitivity of infecting Mycobacteria.
    Type: Grant
    Filed: May 5, 1980
    Date of Patent: October 18, 1983
    Assignee: Montefiore Medical Center
    Inventor: Eugene W. Straus